FDA PMA
FDA Class 3
30-Day Notice Accepted
🇺🇸 United States
Aid, Surgical, Viscoelastic
PMA: P810025
·
Supplement: S024
·
Decision Jul 16, 2004
Classifications
1
FEI Numbers
27
Registration Numbers
27
Basic Information
- Device Name
- Aid, Surgical, Viscoelastic
- Trade Name
- AMVISC & AMVISC PLUS
- PMA Number
- P810025
- Supplement Number
- S024
- Device Class
- FDA Class 3
- Product Code
- LZP
- Generic Name
- AID, SURGICAL, VISCOELASTIC
- Regulation Number
- 886.4275
- Medical Specialty
- Ophthalmic
- Advisory Committee
- Ophthalmic
- Decision
- 30-Day Notice Accepted
- Decision Code
- OK30
- Decision Date
- July 16, 2004
- Date Received
- June 24, 2004
- Supplement Type
- 30-Day Notice
- Supplement Reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Expedited Review
- N
Advisory Committee Statement
ELIMINATION OF THE OWL MONKEY TEST FOR INFLAMMATORY POTENTIAL OF BULK AND FINISHED PRODUCT FORMULATION OF AMVISC & AMVISC PLUS.
Classifications
This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| LZP | Aid, Surgical, Viscoelastic | FDA class 3 | Ophthalmic |